Relative Strength Chart Genmab A/S Nasdaq

Stocks

Market Closed - Nasdaq 06:00:00 12/09/26 am AEST			5-day change	1st Jan Change
32.47 ^USD	+0.74%		-3.36%	+5.42%

08/09	Espiria Hållbar Framtid rose 4.5 percent in August, Vestas and Hansa Biopharma made positive contributions	FW
08/09	Barclays raises Genmab price target to 2,900 Danish kroner (2,500), reiterates overweight - BN	FW

End-of-day quotes

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	GENMAB A/S	Bio Therapeutic Drugs	+0.74%	-3.36%	+5.42%	+16.71%	-26.17%	19.41B	-	-	-